Melanoma
2020 Melanoma Research Highlights
- Exploring Novel Ideas in Melanoma Research
- FY20 Melanoma Research Program: Filling the Gaps in Research for a Better Future
- Siah2: A Potential Biomarker to Predict Immunotherapy Treatment Outcomes in Melanoma Patients
- Role of the Inhibitory Receptor TIGIT in the Regulation of CD4+ Tregs in Patients with Advanced Melanoma
Last updated Thursday, May 26, 2022